David E. Wheadon - 26 May 2022 Form 4 Insider Report for ChemoCentryx, Inc.

Role
Director
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
26 May 2022
Net transactions value
$0
Form type
4
Filing time
31 May 2022, 21:43:57 UTC
Previous filing
17 Jun 2021
Next filing
31 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCXI Restricted Stock Units Award +22,274 22,274 26 May 2022 Common Stock 22,274 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
F2 The restricted stock units awarded on May 26, 2022, vest in three equal installments on May 26, 2023, May 26, 2024, and May 26, 2025, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.